Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideEWEdwards Lifesciences
FinDog View：Neutral
UNHUnitedHealth Group
FinDog View：Neutral
| Metric | EW | UNH |
|---|
| Close | 89.28 | 375.26 |
| Market Cap | $51.5B | $337B |
| 1M | −1.68% | −5.15% |
| P/E (TTM) | 51.2 | 23.9 |
| Forward P/E | 29.8 | 19.7 |
| P/E 5-Yr Percentile | 98 | 53 |
| P/S | 7.9 | 0.8 |
| P/B | 4.9 | 3.2 |
| Dividend Yield | — | 1.37% |
| Latest Quarter Revenue | $1.7B | $112B |
| Revenue YoY | +13.6% | +0.4% |
| Gross Margin | 77.5% | 88.1% |
| Latest Quarter EPS | 0.42 | 6.04 |
| Avg Post-Earnings Move | ±3.9% | ±3.1% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.34% | 2.89% |
| 90-Day Net Insider Buying | −$4.6M | −$0.66M |
EW · Revenue, Last 8 Quarters ($B)
UNH · Revenue, Last 8 Quarters ($B)
